These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 5560389)

  • 1. Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro.
    Crabtree GW; Henderson JF
    Cancer Res; 1971 Jul; 31(7):985-91. PubMed ID: 5560389
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of purine metabolism in Ehrlich ascites tumor cells in vitro.
    Lau KF; Henderson JF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):95-109. PubMed ID: 4499907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of exogenous purines on the biosynthesis and interconversion of purine nucleotides in yeast cells].
    Bekker ML; Luchkina LA; Smolina VS
    Biokhimiia; 1971; 36(5):898-907. PubMed ID: 5129603
    [No Abstract]   [Full Text] [Related]  

  • 4. A kinetic analysis of purine nucleotide synthesis and interconversion in intact Ehrlich ascites tumor cells.
    Snyder FF; Henderson JF
    J Cell Physiol; 1973 Dec; 82(3):349-61. PubMed ID: 4798034
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic regulation of the early steps of purine biosynthesis in Burkitt lymphoma cells and in Ehrlich ascites tumor cells.
    Reem GH
    J Pharmacol Exp Ther; 1974 Oct; 191(1):1-9. PubMed ID: 4371231
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathways of purine ribonucleotide catabolism in Ehrlich ascites tumor cells in vitro.
    Crabtree GW; Henderson JF
    Can J Biochem; 1971 Aug; 49(8):959-63. PubMed ID: 5165993
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors of hypoxanthine metabolism in Ehrlich ascites tumor cells in vitro.
    Smith CM; Zombor G; Henderson JF
    Cancer Treat Rep; 1976 Oct; 60(10):1567-84. PubMed ID: 191189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical effects of formycin, an adenosine analog.
    Henderson JF; Paterson AR; Caldwell IC; Hori M
    Cancer Res; 1967 Apr; 27(4):715-9. PubMed ID: 4290625
    [No Abstract]   [Full Text] [Related]  

  • 9. Sources of nitrogen as rate-limiting factors for purine biosynthesis de novo in Ehrlich ascites tumor cells.
    Fontenelle LJ; Henderson JF
    Biochim Biophys Acta; 1969 Feb; 177(1):88-93. PubMed ID: 4305525
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased feedback inhibition in a 6-(methylmercapto)purine ribonucleoside-resistant tumor.
    Henderson JF; Caldwell IC; Paterson AR
    Cancer Res; 1967 Oct; 27(10):1773-8. PubMed ID: 6064956
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of purine compounds in Ehrlich ascites tumor cells: evidence for a salvage pathway of inosine metabolism.
    Meikle AW; Gotto AM; Touster O
    Biochim Biophys Acta; 1967 May; 138(3):445-51. PubMed ID: 6036845
    [No Abstract]   [Full Text] [Related]  

  • 12. Purine ribonucleotide biosynthesis, interconversion and catabolism in mouse brain in vitro.
    Wong PC; Henderson JF
    Biochem J; 1972 Oct; 129(5):1085-94. PubMed ID: 4348168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic regulation of the adenine nucleotide pool. I. Studies on the transient exhaustion of the adenine nucleotides by glucose in Ehrlich ascites tumor cells.
    Overgaard-Hansen K
    Biochim Biophys Acta; 1965 Jul; 104(2):330-47. PubMed ID: 5892618
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes of purine nucleotide metabolism of Ehrlich ascites cells during transition of tumour growth.
    Grune T; Siems W; Uhlig R; Langen P; Gerber G
    Adv Exp Med Biol; 1991; 309A():109-12. PubMed ID: 1789187
    [No Abstract]   [Full Text] [Related]  

  • 15. [Features of purine compound metabolism in hepatoma 22, mouse liver and erythrocytes during tumor development].
    Tikhonov IuV; Meĭsner IS; Pimenov AM; Toguzov RT
    Vopr Med Khim; 1989; 35(3):125-9. PubMed ID: 2773376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of adenosine and deoxyadenosine in Ehrlich ascites carcinoma cells resistant to 6-(Methylmercapto)purine ribonucleoside.
    Lomax CA; Henderson JF
    Can J Biochem; 1972 Apr; 50(4):423-7. PubMed ID: 4537315
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro studies on the effect of chromomycin A3 on nucleic acid metabolism of Ehrlich ascites tumor cells].
    Ratapongs C
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(2):183-8. PubMed ID: 4239709
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitors of nucleoside and nucleotide metabolism.
    Henderson JF; Paterson AR; Caldwell IC; Paul B; Chan MC; Lau KF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):71-85. PubMed ID: 4676703
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of 3'-amino-3'-deoxyadenosine on nucleic acid synthesis in Ehrlich ascites tumor cells.
    Truman JT; Klenow H
    Mol Pharmacol; 1968 Jan; 4(1):77-86. PubMed ID: 5640781
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of purine ribonucleotide and phosphoribosyl pyrophosphate synthesis by 6-cyclopentylthio-9-hydroxymethylpurine and structurally related compounds.
    Smith CM; Fontenelle LJ; Lalanne M; Henderson JF
    Cancer Res; 1974 Mar; 34(3):463-7. PubMed ID: 4359876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.